PDF
Abstract
In order to investigate the role of Th17 cytokines in the pathogenesis of psoriasis, reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect the expression of IL-17, IL-23 (p19/p40), and IL-6 in skin lesions and non-lesions of the patients with psoriasis and skin tissues of normal subjects. The results showed that the mRNA expression levels of IL-17, IL-23p19, IL-23p40 and IL-6 in psoriasis leision were significantly higher than those of non-leisions (1.231 ± 0.843 vs 1.003 ± 0.044, 1.166 ± 0.142 vs 0.765 ± 0.133, 1.125 ± 0.104 vs 0.730 ± 0.103, 1.186 ± 0.222 vs 0.976 ± 0.122, respectively, all P < 0.05). Meanwhile, The expression levels of IL-17 mRNA, IL-23p19 mRNA, IL-23p40 mRNA and IL-6 mRNA were higher in non-leisions than those in normal skin tissues (1.003 ± 0.044 vs 0.620 ± 0.104, 0.765 ± 0.133 vs 0.584 ± 0.078, 0.730 ± 0.103 vs 0.000 ± 0.000, 0.976 ± 0.122 vs 0.656 ± 0.121, respectively, all P < 0.05). The overexpression of Th17 cytokines in the skin lesions of patients with psoriasis may indicate that Th17 cytokines play a very important role in the immunopathogenesis of psoriasis.
Keywords
psoriasis
/
Th17
/
IL-17
/
IL-23 (p19/p40)
/
IL-6
Cite this article
Download citation ▾
Jiawen Li, Xu’e Chen, Zhixiang Liu, Qing Yue, Houjun Liu.
Expression of Th17 cytokines in skin lesions of patients with psoriasis.
Current Medical Science, 2007, 27(29): 330-332 DOI:10.1007/s11596-007-0329-1
| [1] |
HarringtonL. E., ManganP. R., WeaverC. T.. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol, 2006, 18: 349-356
|
| [2] |
IwakuraY., IshigameH.. The IL-23/IL-17 axis in inflammation. J Clin Invest, 2006, 116: 1218-1222
|
| [3] |
Infante-DuarteC., HortonH. F., ByrneM. C., et al.. Microbial lipopeptides induce the production of IL-17 in Th cell. J Immunol, 2000, 165: 6107-6115
|
| [4] |
DongC.. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol, 2006, 6: 329-333
|
| [5] |
WynnT. A.. T(H)-17: a giant step from T(H)1 and T(H)2. Nat Immunol, 2005, 6: 1069-1070
|
| [6] |
LangrishC. L., ChenY., BlumenscheinW. M., et al.. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med, 2005, 201: 233-240
|
| [7] |
AggarwalS., GhilardiN., XieM. H., et al.. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem, 2003, 278: 1910-1914
|
| [8] |
ChenY., LangrishC. L., MckenzieB., et al.. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest, 2006, 116: 1317-1326
|
